Skip to main content
Category

Uncategorized

qi-lily-blog

Asian Pacific American Community news in the Washington DC metropolitan area – Asian Fortune

By Uncategorized

qi-lily-blog

On a recent business trip to China, I was automatically assumed to be an interpreter or assistant because I was helping with communication on both sides. I had to assert myself and remind my colleagues that I, too, had original thoughts to contribute. This small example shines light on the issue of how Asian women are often perceived. We are seen as competent and hard-working, partly due to stereotypes, but not necessarily powerful or influential. In fact, projecting an image of power can invoke some resentment and cause discomfort. A man I once supervised admitted to me that he was not used to having a woman as manager. At least he was honest, which made it easier to work out the problem.

Read More
collins-cynthia-genvec

GenVec President & CEO Cynthia Collins Joins BioHealth Innovation, Inc. Board of Directors

By Uncategorized

collins-cynthia-genvecROCKVILLE, MARYLAND, February 11, 2013 – BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the appointment of GenVec, Inc. President and Chief Executive Officer Cynthia L. Collins to its Board of Directors. BHI also announced that BHI Founding Board Member Jerry Parrott, formerly with Human Genome Sciences, has stepped down from his board seat but will continue to remain active on BHI’s Commercial Relevance Advisory Board.

Read More
bhi-crab-logo

BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland

By Uncategorized

bhi-crab-logoROCKVILLE, MARYLAND, February 27, 2013 – BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the formation of its Commercial Relevance Advisory Board (CRAB). Members of the CRAB represent diverse business and academic organizations from throughout the region, such as venture capital firm New Enterprise Associates, Ernst & Young, the Howard Hughes Medical Institute, the University of Maryland (UMD), Johns Hopkins University, and leading biotechnology companies.

Read More
bhi-crab-logo

BioHealth Innovation, Inc. Forms Commercial Relevance Advisory Board to Help Advance Market-Relevant Innovations in Central Maryland

By Uncategorized

bhi-crab-logo

BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the formation of its Commercial Relevance Advisory Board (CRAB). Members of the CRAB represent diverse business and academic organizations from throughout the region, such as venture capital firm New Enterprise Associates, Ernst & Young, the Howard Hughes Medical Institute, the University of Maryland (UMD), Johns Hopkins University, and leading biotechnology companies.

The CRAB will assist BHI in evaluating market-relevant research and product development opportunities as well as help determine the commercial applicability of emerging entrepreneurs, companies and their science or technology. BHI will utilize feedback from CRAB members as part of its due diligence process for establishing formal client relationships and potentially future investments.

Read More

Mechanisms, Models, Measurement, Management in Pain Research (R21)- May 07, 2016

By Uncategorized

Funding Opportunity Number: PA-13-119
Opportunity Category: Discretionary
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Income Security and Social Services
CFDA Number: 93.213
93.279
93.361
93.853
93.865
93.866
Eligible Applicants State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
Others (see text field entitled “Additional Information on Eligibility” for clarification)
Agency Name: HHS-NIH11
Closing Date: May 07, 2016
Award Ceiling: $200,000
Expected Number of Awards:
Creation Date: Feb 15, 2013
Funding Opportunity Description: The purpose of this Funding Opportunity Announcement (FOA) is to inform the scientific community of the pain research interests of the various Institutes and Centers (ICs) at the National Institutes of Health (NIH) and to stimulate and foster a wide range of basic, clinical, and translational studies on pain as they relate to the missions of these ICs. New advances are needed in every area of pain research, from the micro perspective of molecular sciences to the macro perspective of behavioral and social sciences. Although great strides have been made in some areas, such as the identification of neural pathways of pain, the experience of pain and the challenge of treatment have remained uniquely individual and unsolved. Furthermore, our understanding of how and why individuals transition to a chronic pain state after an acute injury is limited. Research to address these issues conducted by interdisciplinary and multidisciplinary research teams is strongly encouraged, as is research from underrepresented, minority, disabled, or women investigators.

Read more http://www.grants.gov/search/search.do?mode=VIEW&oppId=220916

Read More
Bendis hi2

Richard Bendis to Discuss EIR Programs at SXSW 2013

By Uncategorized

Bendis hi2sxsw-logo

Richard Bendis will be a speaker at the South by Southwest (SXSW) Conference which takes place from March 8-17 in Austin, Texas. SXSW is a set of film, interactive, and music festivals which occur every year in March. Mr. Bendis will be speaking on March 9th at a session titled “Entrepreneurs in Residence: Not Just for VCs.” In his presentation, Richard will introduce the BioHealth Innovation, Inc. EIR program and speak about some of the commercialization challenges being addressed creatively by the biohealth community in Maryland.

BIO 2013 Chicago Web Graphic 485x100

Richard Bendis to Speak at BIO 2013 Translational Research Forum

By Uncategorized

BIO 2013 Chicago Web Graphic 485x100

Richard Bendis will speak at the Translational Research Forum during the 2013 BIO International Convention in Chicago. During the forum, speakers will address issues with current translational research models, explore new funding and collaboration opportunities, evaluate how to apply them to federal, academic, and private institutions. The session will take place Monday, April 22, from 4:35 p.m. – 5:25 p.m.

More Information

collins-cynthia-genvec

GenVec President & CEO Cynthia Collins Joins BioHealth Innovation, Inc. Board of Directors

By Uncategorized

collins-cynthia-genvec

BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on commercializing market-relevant biohealth innovations and increasing access to early-stage funding in Central Maryland, announced today the appointment of GenVec, Inc. President and Chief Executive Officer Cynthia L. Collins to its Board of Directors. BHI also announced that BHI Founding Board Member Jerry Parrott, formerly with Human Genome Sciences, has stepped down from his board seat but will continue to remain active on BHI’s Commercial Relevance Advisory Board.

“Cindy’s addition to the BHI Board of Directors provides us with access to and perspective from another talented biopharma leader from this region,” said Scott Carmer, BioHealth Innovation, Inc. Chairman of the Board and Executive Vice President of Commercial Operations at MedImmune. “Her tremendous depth and breadth of experience across the industry, particularly with regard to diagnostics as well as therapeutic areas ranging from antivirals to oncology, will be an asset to the companies we work with who are seeking to commercialize biohealth innovations.

Read More
bendis-bhi-cropped

Growing the Region’s Bioscience Community: A Conversation with Richard Bendis, President & CEO of BioHealth Innovation – Baltimore Citybizlist

By Uncategorized

bendis-bhi-cropped

Lets collaborate on building a vibrant biotech (or any other) community! Nice chestnut, but how does one design a community that functions across industries, geographies, support organizations, academic institutions and federal labs, each with very different missions and views of their (and others’) roles? How do you find a shared vision for these variant groups, one that drives growth for the greater region and doesn’t cause the players for fight over each opportunity as if it is the last scrap of possibility we’ll see? How do you prevent such a vision from becoming another dusty whitepaper, where behaviors weren’t aligned to make it happen?  I had a chance to discuss how such a collaboration should be designed with Rich Bendis, President & CEO of BioHealth Innovation (BHI), an organization which spans from Rockville to Baltimore.

Read More

Search

You have successfully subscribed to the newsletter

There was an error while trying to send your request. Please try again.

BioHealth Innovation will use the information you provide on this form to be in touch with you and to provide updates and marketing.